Antibodies against PM/Scl-75 and PM/Scl-100 are independent markers for different subsets of systemic sclerosis patients
Open Access
- 1 January 2009
- journal article
- Published by Springer Science and Business Media LLC in Arthritis Research & Therapy
- Vol. 11 (1), R22
- https://doi.org/10.1186/ar2614
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Novel aspects of autoantibodies to the PM/Scl complex: Clinical, genetic and diagnostic insightsAutoimmunity Reviews, 2007
- Anti-pm/scl antibodies in connective tissue disease: Clinical and biological assessment of 14 patients.2006
- Autoantibodies in Systemic SclerosisSeminars in Arthritis and Rheumatism, 2005
- PM–Scl‐75 is the main autoantigen in patients with the polymyositis/scleroderma overlap syndromeArthritis & Rheumatism, 2004
- The Association of the Human PM/Scl-75 Autoantigen with the Exosome Is Dependent on a Newly Identified N TerminusJournal of Biological Chemistry, 2003
- The Clinical and Immunogenetic Features of Patients with Autoantibodies to the Nucleolar Antigen PM-SclMedicine, 1992
- Serum autoantibody to the nucleolar antigen PM‐Scl. Clinical and immunogenetic associationsArthritis & Rheumatism, 1992
- Cloning and characterization of the cDNA coding for a polymyositis-scleroderma overlap syndrome-related nucleolar 100-kD protein.The Journal of Experimental Medicine, 1992
- Molecular characterization of an autoantigen of PM-Scl in the polymyositis/scleroderma overlap syndrome: a unique and complete human cDNA encoding an apparent 75-kD acidic protein of the nucleolar complex.The Journal of Experimental Medicine, 1991
- Antibodies to a nuclear/nucleolar antigen in patients with polymyositis overlap syndromesJournal of Clinical Immunology, 1984